Relay Therapeutics (RLAY) Current Leases (2019 - 2026)
Relay Therapeutics (RLAY) reported Current Leases of $3.9 million for Q1 2026, down 34.44% year-over-year from $5.9 million in Q1 2025, and up 3.27% quarter-over-quarter from $3.8 million in Q4 2025.
Relay Therapeutics (RLAY) Current Leases (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 8 years of Current Leases data on file, last reported at $3.9 million in Q1 2026.
- Current Leases for Q1 2026 came in at $3.9 million, down 34.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (down 34.44% YoY), and the FY2025 annual result was $3.8 million, down 34.26% from the prior year.
- Current Leases rose to $3.9 million in Q1 2026 per RLAY's latest filing, from $3.8 million in the prior quarter.
- Over five years, Current Leases peaked at $5.9 million in Q1 2025 and troughed at $1.9 million in Q1 2022.
- A 5-year average of $4.4 million and a median of $4.6 million in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2026: Current Leases surged 221.32% in 2022, then tumbled 34.44% in 2026.
- A 5-year view of Current Leases shows it stood at $4.3 million in 2022, then rose by 16.09% to $5.0 million in 2023, then rose by 15.37% to $5.7 million in 2024, then slumped by 34.26% to $3.8 million in 2025, then gained by 3.27% to $3.9 million in 2026.
- Business Quant data shows RLAY's Current Leases at $3.9 million in Q1 2026, $3.8 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | 3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.89 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 3.53 Mn |
| Mar 31, 2025 | 5.93 Mn |
| Dec 31, 2024 | 5.73 Mn |
| Sep 30, 2024 | 5.53 Mn |
| Jun 30, 2024 | 5.34 Mn |
| Mar 31, 2024 | 5.15 Mn |
| Dec 31, 2023 | 4.96 Mn |
| Sep 30, 2023 | 4.79 Mn |
| Jun 30, 2023 | 4.61 Mn |
| Mar 31, 2023 | 4.44 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 5.68 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | 1.70 Mn |